Brand name: ALIEMPAGLIFLOZIN+ALILINAGLIPTIN
Composition:
Each tablet contains:
Empagliflozin………………………….10mg
Linagliptin……………………………….5mg
Indications:
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Dosage:
- Please use according to your doctor’s instructions.
- Take one tablet once daily in the morning with or without meals.
Contraindications:
- Allergic to Empagliflozin, Linagliptin or any excipients in this product.
- Dialysis patients.
- Pancreatitis patients.
Warnings:
- This product is not applicable to type I diabetes or type I diabetes ketoacidosis.
- Stop taking this product immediately if symptoms of pancreatitis appear.
- Beware of hypoglycemia during use.
- May increase the risk of reproductive fungal infections.
- Not recommended for pregnant and lactating women.
Adverse Effects:
Urinary tract infections, nasopharyngitis and upper respiratory tract infections.
Dosage form: White tablets.
Expiry date: 24 months after date of manufacture.
Packaging: 7 tablets/blister, 2 blisters/box.
Storage:
- Protected from light, sealed, and stored at 20℃- 25℃.
- Keep out of reach of children.
DISCLAIMER
The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
For your safety:
Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.
